Comparison of the Efficacy and Safety of Nivolumab Plus Cabozantinib versus Sunitinib in the Treatment of Elderly Patients with Advanced Clear Cell Renal Cell Carcinoma

Yanjie Liu, Ying Meng, Mengmeng Li, Yanjiao Dong

PDF(733 KB)
AEU
Archivos Españoles de Urología ›› 2024, Vol. 77 ›› Issue (5) : 584-590. DOI: 10.56434/j.arch.esp.urol.20247705.79
Article

Comparison of the Efficacy and Safety of Nivolumab Plus Cabozantinib versus Sunitinib in the Treatment of Elderly Patients with Advanced Clear Cell Renal Cell Carcinoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 77(5): 584-590 https://doi.org/10.56434/j.arch.esp.urol.20247705.79

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
Article Options
  • PDF (194 views)
  • Full Text ( views)

Accesses

Citation

Detail
Sections
Recommended

Journal Info

About AEU
Indexing & Archiving
Editorial Board
Open Access
Copyright & License

For Authors

Submit
Instructions for Authors
Editorial Process
Article Processing Charge

For Reviewers

Online Review
Guidelines for Reviewers
Peer Review Process
Reviewer Board

Articles

Current Issue
Archives
Follow Us on
Copyright © 2023.
  • Disclaimer
    The statements, opinions and data contained in Archivos Españoles de Urología are solely those of the individual authors and contributors and not of the journal and the editor(s). Archivos Españoles de Urología stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.
    • 　　Terms & Conditions　　 Terms & Use　　　 Privacy Policy　

    /

    〈 〉